{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T03:20:53Z","timestamp":1792552853034,"version":"4.5.0"},"reference-count":47,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.3201\/eid2706.203850","type":"journal-article","created":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T09:04:56Z","timestamp":1621415096000},"page":"1561-1566","source":"Crossref","is-referenced-by-count":102,"title":["Pertactin-Deficient\n                    <i>Bordetella pertussis<\/i>\n                    , Vaccine-Driven Evolution, and Reemergence of Pertussis"],"prefix":"10.3201","volume":"27","author":[{"given":"Longhuan","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Caulfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalyan K.","family":"Dewan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric T.","family":"Harvill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2706.203850-202105162141-R1","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1017\/S0950268812003093","article-title":"Perplexities of pertussis: recent global epidemiological trends and their potential causes.","volume":"142","author":"Jackson","year":"2014","journal-title":"Epidemiol Infect"},{"key":"key-10.3201\/eid2706.203850-202105162141-R2","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1128\/CVI.00717-13","article-title":"Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States.","volume":"21","author":"Pawloski","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"key-10.3201\/eid2706.203850-202105162141-R3","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1073\/pnas.1314688110","article-title":"Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model.","volume":"111","author":"Warfel","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.3201\/eid2706.203850-202105162141-R4","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1086\/422035","article-title":"Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study.","volume":"190","author":"Le","year":"2004","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2706.203850-202105162141-R5","doi-asserted-by":"publisher","first-page":"e20153973","DOI":"10.1542\/peds.2015-3973","article-title":"Pertussis vaccine effectiveness in the setting of pertactin-deficient pertussis.","volume":"137","author":"Breakwell","year":"2016","journal-title":"Pediatrics"},{"key":"key-10.3201\/eid2706.203850-202105162141-R6","doi-asserted-by":"publisher","first-page":"1700832","DOI":"10.2807\/1560-7917.ES.2019.24.7.1700832","article-title":"Pertactin-deficient Bordetella pertussis isolates: evidence of increased circulation in Europe, 1998 to 2015.","volume":"24","author":"Barkoff","year":"2019","journal-title":"Euro Surveill"},{"key":"key-10.3201\/eid2706.203850-202105162141-R7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/cid\/ciu788","article-title":"Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage.","volume":"60","author":"Martin","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2706.203850-202105162141-R8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1471-2334-6-53","article-title":"Analysis of Bordetella pertussis pertactin and pertussis toxin types from Queensland, Australia, 1999-2003.","volume":"6","author":"Byrne","year":"2006","journal-title":"BMC Infect Dis"},{"key":"key-10.3201\/eid2706.203850-202105162141-R9","doi-asserted-by":"publisher","first-page":"780","DOI":"10.3201\/eid2504.180812","article-title":"Genomic survey of Bordetella pertussis diversity, United States, 2000\u20132013.","volume":"25","author":"Weigand","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2706.203850-202105162141-R10","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3201\/eid2304.161575","article-title":"Significant decrease in pertactin-deficient Bordetella pertussis isolates, Japan.","volume":"23","author":"Hiramatsu","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2706.203850-202105162141-R11","doi-asserted-by":"publisher","first-page":"e000180","DOI":"10.1099\/mgen.0.000180","article-title":"Bordetella pertussis population dynamics and phylogeny in Japan after adoption of acellular pertussis vaccines.","volume":"4","author":"Zomer","year":"2018","journal-title":"Microb Genom"},{"key":"key-10.3201\/eid2706.203850-202105162141-R12","doi-asserted-by":"publisher","first-page":"e31985","DOI":"10.1371\/journal.pone.0031985","article-title":"Prevalence and genetic characterization of pertactin-deficient Bordetella pertussis in Japan.","volume":"7","author":"Otsuka","year":"2012","journal-title":"PLoS One"},{"key":"key-10.3201\/eid2706.203850-202105162141-R13","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s12864-020-6724-8","article-title":"Comparative genomics of whole-cell pertussis vaccine strains from India.","volume":"21","author":"Alai","year":"2020","journal-title":"BMC Genomics"},{"key":"key-10.3201\/eid2706.203850-202105162141-R14","doi-asserted-by":"publisher","first-page":"e18014","DOI":"10.1371\/journal.pone.0018014","article-title":"Studies on Prn variation in the mouse model and comparison with epidemiological data.","volume":"6","author":"van Gent","year":"2011","journal-title":"PLoS One"},{"key":"key-10.3201\/eid2706.203850-202105162141-R15","doi-asserted-by":"publisher","first-page":"6277","DOI":"10.1016\/j.vaccine.2015.09.064","article-title":"Pertactin negative Bordetella pertussis demonstrates higher fitness under vaccine selection pressure in a mixed infection model.","volume":"33","author":"Safarchi","year":"2015","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2706.203850-202105162141-R16","doi-asserted-by":"publisher","first-page":"6597","DOI":"10.1016\/j.vaccine.2014.09.068","article-title":"Pertactin deficient Bordetella pertussis present a better fitness in mice immunized with an acellular pertussis vaccine.","volume":"32","author":"Hegerle","year":"2014","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2706.203850-202105162141-R17","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1128\/IAI.56.12.3189-3195.1988","article-title":"Identification of a 69-kilodalton nonfimbrial protein as an agglutinogen of Bordetella pertussis.","volume":"56","author":"Brennan","year":"1988","journal-title":"Infect Immun"},{"key":"key-10.3201\/eid2706.203850-202105162141-R18","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/S0966-842X(98)01318-3","article-title":"The great escape: structure and function of the autotransporter proteins.","volume":"6","author":"Henderson","year":"1998","journal-title":"Trends Microbiol"},{"key":"key-10.3201\/eid2706.203850-202105162141-R19","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1574-6968.2007.00833.x","article-title":"Autotransporter proteins: novel targets at the bacterial cell surface.","volume":"274","author":"Wells","year":"2007","journal-title":"FEMS Microbiol Lett"},{"key":"key-10.3201\/eid2706.203850-202105162141-R20","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1099\/13500872-142-11-3261","article-title":"Role of the Bordetella pertussis P.69\/pertactin protein and the P.69\/pertactin RGD motif in the adherence to and invasion of mammalian cells.","volume":"142","author":"Everest","year":"1996","journal-title":"Microbiology (Reading)"},{"key":"key-10.3201\/eid2706.203850-202105162141-R21","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1073\/pnas.88.2.345","article-title":"Pertactin, an Arg-Gly-Asp-containing Bordetella pertussis surface protein that promotes adherence of mammalian cells.","volume":"88","author":"Leininger","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.3201\/eid2706.203850-202105162141-R22","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1006\/jmbi.1994.1029","article-title":"Crystallographic characterization of pertactin, a membrane-associated protein from Bordetella pertussis.","volume":"235","author":"Emsley","year":"1994","journal-title":"J Mol Biol"},{"key":"key-10.3201\/eid2706.203850-202105162141-R23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/381090a0","article-title":"Structure of Bordetella pertussis virulence factor P.69 pertactin.","volume":"381","author":"Emsley","year":"1996","journal-title":"Nature"},{"key":"key-10.3201\/eid2706.203850-202105162141-R24","doi-asserted-by":"publisher","first-page":"4918","DOI":"10.1073\/pnas.0507923103","article-title":"Pertactin \u03b2-helix folding mechanism suggests common themes for the secretion and folding of autotransporter proteins.","volume":"103","author":"Junker","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.3201\/eid2706.203850-202105162141-R25","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1128\/IAI.00188-10","article-title":"Pertactin is required for Bordetella species to resist neutrophil-mediated clearance.","volume":"78","author":"Inatsuka","year":"2010","journal-title":"Infect Immun"},{"key":"key-10.3201\/eid2706.203850-202105162141-R26","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41426-018-0039-8","article-title":"Bordetella pertussis pertactin knock-out strains reveal immunomodulatory properties of this virulence factor.","volume":"7","author":"Hovingh","year":"2018","journal-title":"Emerg Microbes Infect"},{"key":"key-10.3201\/eid2706.203850-202105162141-R27","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/ng1227","article-title":"Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica.","volume":"35","author":"Parkhill","year":"2003","journal-title":"Nat Genet"},{"key":"key-10.3201\/eid2706.203850-202105162141-R28","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1099\/mic.0.000197","article-title":"Diversity of secretion systems associated with virulence characteristics of the classical bordetellae.","volume":"161","author":"Park","year":"2015","journal-title":"Microbiology (Reading)"},{"key":"key-10.3201\/eid2706.203850-202105162141-R29","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1186\/s12864-016-3112-5","article-title":"Acquisition and loss of virulence-associated factors during genome evolution and speciation in three clades of Bordetella species.","volume":"17","author":"Linz","year":"2016","journal-title":"BMC Genomics"},{"key":"key-10.3201\/eid2706.203850-202105162141-R30","doi-asserted-by":"publisher","first-page":"751","DOI":"10.3390\/vaccines3030751","article-title":"New data on vaccine antigen deficient Bordetella pertussis isolates.","volume":"3","author":"Bouchez","year":"2015","journal-title":"Vaccines (Basel)"},{"key":"key-10.3201\/eid2706.203850-202105162141-R31","doi-asserted-by":"publisher","first-page":"6034","DOI":"10.1016\/j.vaccine.2009.07.074","article-title":"First report and detailed characterization of B. pertussis isolates not expressing Pertussis Toxin or Pertactin.","volume":"27","author":"Bouchez","year":"2009","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2706.203850-202105162141-R32","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1128\/microbiolspec.PSIB-0024-2018","article-title":"Bordetella filamentous hemagglutinin, a model for the two-partner secretion pathway.","volume":"7","author":"Nash","year":"2019","journal-title":"Microbiol Spectr"},{"key":"key-10.3201\/eid2706.203850-202105162141-R33","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1086\/377283","article-title":"Crucial role of antibodies to pertactin in Bordetella pertussis immunity.","volume":"188","author":"Hellwig","year":"2003","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2706.203850-202105162141-R34","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1128\/IAI.67.3.1424-1431.1999","article-title":"Characterization of human bactericidal antibodies to Bordetella pertussis.","volume":"67","author":"Weiss","year":"1999","journal-title":"Infect Immun"},{"key":"key-10.3201\/eid2706.203850-202105162141-R35","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/nrmicro1824","article-title":"Complement evasion by human pathogens.","volume":"6","author":"Lambris","year":"2008","journal-title":"Nat Rev Microbiol"},{"key":"key-10.3201\/eid2706.203850-202105162141-R36","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00109-015-1259-1","article-title":"Complement evasion by Bordetella pertussis: implications for improving current vaccines.","volume":"93","author":"Jongerius","year":"2015","journal-title":"J Mol Med (Berl)"},{"key":"key-10.3201\/eid2706.203850-202105162141-R37","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJM199602083340601","article-title":"A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis.","volume":"334","author":"Greco","year":"1996","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2706.203850-202105162141-R38","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1056\/NEJM199602083340602","article-title":"A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine.","volume":"334","author":"Gustafsson","year":"1996","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2706.203850-202105162141-R39","doi-asserted-by":"publisher","first-page":"ftv071","DOI":"10.1093\/femspd\/ftv071","article-title":"Waning and aging of cellular immunity to Bordetella pertussis.","volume":"73","author":"van Twillert","year":"2015","journal-title":"Pathog Dis"},{"key":"key-10.3201\/eid2706.203850-202105162141-R40","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1016\/j.vaccine.2012.02.013","article-title":"Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine.","volume":"30","author":"Tomovici","year":"2012","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2706.203850-202105162141-R41","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1086\/315318","article-title":"Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis.","volume":"181","author":"Taranger","year":"2000","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2706.203850-202105162141-R42","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1001\/jama.2014.3633","article-title":"Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial.","volume":"311","author":"Munoz","year":"2014","journal-title":"JAMA"},{"key":"key-10.3201\/eid2706.203850-202105162141-R43","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1093\/infdis\/jiv324","article-title":"The decline of pertussis-specific antibodies after tetanus, diphtheria, and acellular pertussis immunization in late pregnancy.","volume":"212","author":"Abu Raya","year":"2015","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2706.203850-202105162141-R44","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1086\/381439","article-title":"Serologic response and antibody-titer decay in adults with pertussis.","volume":"38","author":"Heininger","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2706.203850-202105162141-R45","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/S0264-410X(98)00227-8","article-title":"Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis.","volume":"16","author":"Storsaeter","year":"1998","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2706.203850-202105162141-R46","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.3389\/fmicb.2020.02108","article-title":"Acellular pertussis vaccines induce anti-pertactin bactericidal antibodies which drives the emergence of pertactin-negative strains.","volume":"11","author":"Lesne","year":"2020","journal-title":"Front Microbiol"},{"key":"key-10.3201\/eid2706.203850-202105162141-R47","doi-asserted-by":"publisher","first-page":"e0195979","DOI":"10.1371\/journal.pone.0195979","article-title":"Clinical evaluation and validation of laboratory methods for the diagnosis of Bordetella pertussis infection: Culture, polymerase chain reaction (PCR) and anti-pertussis toxin IgG serology (IgG-PT).","volume":"13","author":"Lee","year":"2018","journal-title":"PLoS One"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/27\/6\/20-3850_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T12:52:09Z","timestamp":1732971129000},"score":1,"resource":{"primary":{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/27\/6\/20-3850_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2706.203850","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6]]}}}